Financial News Feed

Previous Hold Today ACST ranks #3452 as HOLD CANDIDATE. Next Hold
Today ACST ranks #3452 as HOLD CANDIDATE.

ACST stock Acasti Pharma

BUY SELL

ACST stock
Acasti Pharma

BUY SELL
Watchlist
Share on StockTwits
Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ
Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ
Watchlist
Share on StockTwits
...
Acasti Pharma Inc. (ACST) Analysts See $-0.08 EPS | Thorold News
 01:09am, Saturday, 19'th Jan 2019
Analysts expect Acasti Pharma Inc. (NASDAQ:ACST) to report $-0.08 EPS on February, 12.They anticipate $0.23 EPS change or 74.19 % from last quarter's $-0.31...

Read more

...
Acasti Pharma (ACST) Downgraded by Zacks Investment Research
 12:04pm, Friday, 18'th Jan 2019
Zacks Investment Research downgraded shares of Acasti Pharma (NASDAQ:ACST) from a buy rating to a hold rating in a research note published on Monday. According to Zacks, “Acasti Pharma Inc. is a bio...

Read more

...
Acasti Pharma (ACST) Cut to Hold at Zacks Investment Research
 08:02am, Thursday, 17'th Jan 2019
Zacks Investment Research lowered shares of Acasti Pharma (NASDAQ:ACST) from a buy rating to a hold rating in a report published on Monday morning. According to Zacks, “Acasti Pharma Inc. is a bioph...

Read more

...
Acasti Pharma (ACST) Shares Climb Above Balance Step
 08:42am, Wednesday, 16'th Jan 2019
Acasti Pharma (ACST) shares are on close watch heading into the week as the price has moved above the Balance Step indicator, revealing a potential near-term bullish uptrend. The Balance Step formula ...

Read more

...
$-0.08 EPS Expected for Acasti Pharma Inc. (ACST) | Thorold News
 04:37am, Wednesday, 16'th Jan 2019
Analysts expect Acasti Pharma Inc. (NASDAQ:ACST) to report $-0.08 EPS on February, 12.They anticipate $0.23 EPS change or 74.19 % from last quarter's $-0.31...

Read more

...
Acasti Pharma (ACST) Stock Rating Lowered by Zacks Investment Research
 03:46am, Wednesday, 16'th Jan 2019
Acasti Pharma (NASDAQ:ACST) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Monday. According to Zacks, “Acasti P...

Read more

...
Acasti Pharma (ACST) Downgraded to Hold at Zacks Investment Research
 08:44am, Tuesday, 15'th Jan 2019
Zacks Investment Research cut shares of Acasti Pharma (NASDAQ:ACST) from a buy rating to a hold rating in a research report sent to investors on Monday morning. According to Zacks, “Acasti Pharma In...

Read more

...
What is The Twiggs Money Flow Implying for Acasti Pharma (ACST)?
 08:03pm, Monday, 14'th Jan 2019
Acasti Pharma (ACST) shares are being closely watched by investors as the Twiggs Money Flow indicator has jolted above the zero line. This typically indicates that further upside is ahead for the shar...

Read more

...
Acasti Pharma (ACST) Collects Gains of 27.78% For the Week
 05:37pm, Sunday, 13'th Jan 2019
Acasti Pharma (ACST) shares are showing positive signals short-term as the stock has finished higher by 27.78% for the week. In taking a look at recent performance, we can see that shares have moved 7...

Read more

...
MA Rating Watch on Shares of Acasti Pharma Inc. (NASDAQ:ACST): Rating at Strong Buy
 12:52pm, Sunday, 13'th Jan 2019
Successful stock market traders and investors don’t usually just become that way overnight. There are often many years of experience behind those winning trades. The amount of data available to inve...

Read more

...
Acasti Pharma (ACST) CMF Showing Increased Buying Pressure
 02:03am, Sunday, 13'th Jan 2019
Acasti Pharma (ACST) is seeing positive money flow as the Chalkin (CMF) indicator is holding above the zero line. The Chaikin Money Flow Indicator is an oscillator developed by Marc Chaikin. An oscill...

Read more

...
Technical Tracker: Following Shares of Acasti Pharma (ACST)
 08:55pm, Saturday, 12'th Jan 2019
Monitoring the indicators for Acasti Pharma (ACST), we have noticed that the Plus Directional Indicator is currently higher than the Minus Directional Indicator. With the +DI above the -DI, traders ma...

Read more

...
Acasti Pharma Inc. (NASDAQ:ACST) Runs 27.78% For the Week
 03:18pm, Saturday, 12'th Jan 2019
Acasti Pharma Inc. (NASDAQ:ACST) shares have moved 27.78% on the week. The stock closed the most recent session at $1.15 after seeing 746260 shares trade hands. This represents a change of 4.55% from ...

Read more

...
Acasti Pharma Inc. (ACST) Analysts See $-0.08 EPS
 02:35am, Saturday, 12'th Jan 2019
Analysts expect Acasti Pharma Inc. (NASDAQ:ACST) to report $-0.08 EPS on February, 12.They anticipate $0.23 EPS change or 74.19 % from last quarter's $-0.31...

Read more

...
Acasti Pharma (ACST) Shares Tumble -21.43% For the Quarter
 07:09pm, Friday, 11'th Jan 2019
Shares of Acasti Pharma (ACST) have been tilting lower over the past 13 weeks, revealing bearish momentum for the shares, as they have dipped -21.43% over the past quarter. Looking further out we note...

Read more

News Feed powered by

StockInvest.us

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank